Price (delayed)
$81.19
Market cap
$4.08B
P/E Ratio
33.41
Dividend/share
N/A
EPS
$2.43
Enterprise value
$5B
Haemonetics is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of
There are no recent dividends present for HAE.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.